基因組學市場規模、佔有率及成長分析（按產品、產品類型、技術、服務類型、應用、研究類型、最終用戶和地區）－2025 年至 2032 年產業預測

預計基因組學市場規模在 2023 年將達到 371 億美元，並將從 2024 年的 416.6 億美元成長到 2032 年的 1053.9 億美元，預測期內（2025-2032 年）的複合年成長率為 12.3%。

隨著我們對 DNA 結構、功能和圖譜的理解不斷加深，基因組學領域正在經歷重大變革。隨著全球癌症發生率的增加，政府對創新基因組學計劃的支持力度也越來越大。這種擴散促進了個人化醫療的出現，徹底改變了臨床腫瘤學和罕見遺傳疾病的治療策略。同時，學術界正深入研究遺傳學與認知障礙的關聯性，進一步拓展基因體學的應用領域。對癌症研究的日益關注，加上對快速臨床診斷的需求，再加上政府機構和生物製藥公司的大力投資，正在推動基因組學市場收益快速成長。這種多方面的演化反映了基因組學對醫療保健和醫學科學的深遠影響。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析
• 專利分析
• 監管分析
• 技術分析
• 案例研究

基因組學市場規模（按產品）

• 市場概覽
• 產品
• 服務

基因組學市場規模（按產品類型）

• 市場概覽
• 試劑、套件及耗材
• 裝置
• 生物資訊學工具

基因組學市場規模（按技術）

• 市場概覽
• 定序
• PCR
• 基因編輯
• 流式細胞技術
• 微陣列
• 原位雜合技術
• 其他技術

基因組學市場規模（按服務類型）

• 市場概覽
• 基因組分析與定序服務
• 樣本和樣品製備服務
• 生物資訊服務

基因組學市場規模（按應用）

• 市場概覽
• 藥物研發
• 診斷
  • 感染疾病
  • 生殖健康
  • 其他診斷應用
  • 農業和動物研究
• 其他用途

基因組學市場規模（依研究類型）

• 市場概覽
• 功能基因體學
• 生物標記發現
• 通路分析
• 表觀基因
• 其他類型的研究

基因組學市場規模（按最終用戶分類）

• 市場概覽
• 醫院、診斷實驗室和診所
• 學術研究所
• 製藥和生物技術公司
• 其他最終用戶

基因組學市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Illumina, Inc.（US）
• Thermo Fisher Scientific（US）
• Qiagen NV（Netherlands）
• BGI Group（China）
• F. Hoffmann-La Roche AG（Switzerland）
• Danaher Corporation（US）
• Pacific Biosciences of California, Inc.（US）
• Oxford Nanopore Technologies, Ltd.（United Kingdom）
• Eurofins Scientific SE（Luxembourg）
• Bio-Rad Laboratories, Inc.（US）
• Myriad Genetics, Inc.（US）
• Fluidigm Corporation（US）
• PerkinElmer, Inc.（US）
• Twist Bioscience Corporation（US）
• Natera, Inc.（US）
• Veracyte, Inc.（US）
• Personalis, Inc.（US）
• 10x Genomics, Inc.（US）
• Quest Diagnostics（US）

結論和建議

Genomics Market size was valued at USD 37.1 billion in 2023 and is poised to grow from USD 41.66 billion in 2024 to USD 105.39 billion by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).

The genomics sector is witnessing significant transformation, driven by advancements in the understanding of DNA structure, function, and mapping. As the global incidence of cancer escalates, so does government support, with increased funding fueling innovative genomics projects. This surge has enabled the emergence of personalized medicine, revolutionizing treatment strategies in clinical oncology and rare genetic disorders. Concurrently, academia is delving into the correlations between genetics and cognitive disorders, further expanding genomics applications. The heightened focus on cancer research, coupled with a demand for expedited clinical diagnostics and robust investments from government bodies and biopharmaceutical firms, is propelling the genomics market towards rapid revenue growth. This multifaceted evolution reflects the profound impact genomics has on healthcare and medical sciences.

Top-down and bottom-up approaches were used to estimate and validate the size of the Genomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Genomics Market Segments Analysis

Global Genomics Market is segmented by Offering, Product Type, Technology, Service Type, Application, Study Type, End User and region. Based on Offering, the market is segmented into Products and Services. Based on Product Type, the market is segmented into Reagents, Kits, And Consumables, Instruments and Bioinformatics Tools. Based on Technology, the market is segmented into Sequencing, PCR, Gene Editing,Flow Cytometry, Microarrays, In Situ Hybridization and Other Technologies. Based on Service Type, the market is segmented into Genomic Profiling and Sequencing Services, Sample Preparation and Library Preparation Services and Bioinformatics Services. Based on Application, the market is segmented into Drug Discovery and Development, Diagnostics and Other Applications. Based on Study Type, the market is segmented into Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics and Other Study Types. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, and Clinics, Academic and Research Institutes, Pharmaceutical And Biotechnology Companies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Genomics Market

The Genomics market is experiencing significant growth due to the expanding utilization of Next-Generation Sequencing (NGS) in various applications, particularly in cancer research. This technology encompasses a range of uses, including whole-genome sequencing, the exploration of genomic diversity, metagenomics, epigenetic studies, the identification of non-coding RNAs and protein-binding sites, as well as gene-expression profiling via RNA sequencing. Each of these applications enhances our understanding of genetics and disease, thereby fueling demand in the Genomics market. The increasing reliance on NGS technologies signifies their crucial role in advancing genomic studies and innovations.

Restraints in the Genomics Market

The genomics market is facing potential challenges, particularly regarding the availability of skilled personnel, which is a common constraint in many industries. Additionally, the high costs associated with genomic equipment and the complexities of data storage-stemming from sequenced data between 2023 and 2031-may hinder market growth. While the incorporation of genomic technologies in healthcare has the capacity to improve safety, quality, efficiency, and overall cost-effectiveness, realizing these advantages is heavily contingent upon having access to qualified professionals. Thus, without addressing these limitations, the expansion and effectiveness of the genomics market could be significantly impacted.

Market Trends of the Genomics Market

The genomics market is witnessing a pivotal shift as Illumina phases out its OmniExpress chip in favor of the customized Global Screening Array (GSA) microarray. This transition is compelling companies like Ancestry.com to adapt quickly by either adopting the GSA, integrating Thermo Fisher Scientific products, or investing in next-generation sequencing (NGS) technology. This trend underscores a broader movement within the genomics industry toward enhanced precision, scalability, and cost-effectiveness in genetic analysis. As organizations pivot to maintain competitive advantages, the demand for innovative sequencing solutions is expected to accelerate, driving growth and transformation in the genomics landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Genomics Market Size by Offering & CAGR (2025-2032)

• Market Overview
• Products
• Services

Global Genomics Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Reagents, Kits, And Consumables
• Instruments
• Bioinformatics Tools

Global Genomics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Sequencing
• PCR
• Gene Editing
• Flow Cytometry
• Microarrays
• In Situ Hybridization
• Other Technologies

Global Genomics Market Size by Service Type & CAGR (2025-2032)

• Market Overview
• Genomic Profiling and Sequencing Services
• Sample Preparation and Library Preparation Services
• Bioinformatics Services

Global Genomics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery and Development
• Diagnostics
  • Infectious Diseases
  • Reproductive Health
  • Other Diagnostic Applications
  • Agriculture And Animal Research
• Other Applications

Global Genomics Market Size by Study Type & CAGR (2025-2032)

• Market Overview
• Functional Genomics
• Biomarker Discovery
• Pathway Analysis
• Epigenomics
• Other Study Types

Global Genomics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals, Diagnostic Laboratories, and Clinics
• Academic and Research Institutes
• Pharmaceutical And Biotechnology Companies
• Other End Users

Global Genomics Market Size & CAGR (2025-2032)

• North America (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
  • US
  • Canada
• Europe (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies, Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veracyte, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Personalis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations